Glubran- 2 Acrylic Glue for Percutaneous Embolization of Intramuscular Vascular Malformations of Lower Limbs: Preliminary Experience


Acrylic glue
percutaneous embolization
arteriovenous malformations
venous malformations

How to Cite

Stillo, F., Ruggiero, F., Mattassi, R., Amato, B., & Compagna, R. (2020). Glubran- 2 Acrylic Glue for Percutaneous Embolization of Intramuscular Vascular Malformations of Lower Limbs: Preliminary Experience. Journal of Basic & Applied Sciences, 16, 79–87.


Aims: Vascular anomalies (VA) represent a heterogeneous and rare group of pathologies. Ethanol is considered the gold standard in endovascular embolization procedures, but its use exposes to the risk of major complications. Glubran-2 is a new glue agent, used mainly for catheter-based cerebral embolization. Our study reported preliminary experiences with a group of 13 patients treated for intramuscular VA of limbs with Glubran-2 solution by venous retrograde percutaneous embolization.

Methods: Through an Angiographic CT/MRI we selected 13 adult patients (6 males, 7 females), seven with limb AVMs and six with limb VM, all intramuscular. All patients reported pain and functional limitation as presenting symptoms. Glubran-2 was injected under fluoroscopic guidance through multiple percutaneous punctures, to cover the entire extension of the lesion.

Results: In the 6-month follow-up, all patients reported pain reduction, rapid recovery of function, favourable post-operative course and absence of major complications. Angio-RMI control was performed in all patients. It showed Glubran-2 in place and the exclusion of the malformation. Percutaneous retrograde embolization with Glubran-2 permanently excluded muscle malformations from circulation: only one embolization procedure was, in 12 of 13 patients, sufficient for a complete and definitive treatment. Rapid polymerization of Glubran-2 glue, after its injection, cancelled the risk of pulmonary embolisms and skin necrosis. Secondary surgical removal was never necessary to complete treatment of these deep muscle malformations.

Conclusions: This study showed that the percutaneous embolization technique with Glubran-2 glue can be considered favorable in the treatment of the VA of the limbs for its easier handling and promising outcome.


Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg 2011; 127(01): 347-351.

Wassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136(01): e203-e214.

Stillo F, Baraldini V, Dalmonte P, El Hachem M, Mattassi R, Vercellio G, et al. Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV). International Angiology 2015; 34(2 Suppl 1): 1-45.

Gloviczki P, Duncan A, Kalra M, et al. Vascular malformations: an update. Perspect Vasc Surg Endovasc Ther 2009; 21: 133-148.

Mattassi R. Surgical treatment of congenital arteriovenous defects. Int Angiol 1990; 9: 196-202.

Lee B-B, Do YS, Yakes W, et al. Management of arteriovenous malformations: A multidisciplinary approach. J Vasc Surg 2004; 39: 590.

Visser A, FitzJohn T, Tan ST. Surgical management of arteriovenous malformation. J Plast Reconstr Aesthet Surg 2011; 64: 283.

McCafferty IJ, Jones RG. Imaging and management of vascular malformations. Clin Radiol 2011; 66: 1208.

Linden E, Baalen JM, Pattynama PMT. Retrograde transvenous ethanol embolization of high-flow peripheral arteriovenous malformations. Cardiovasc Intervent Radiol 2011; 35: 820.

Bianchini G, Camilli D and Furgiuele S. Intramuscular Venous Malformations of the Upper and Lower Limbs: Indications and Outcomes of Sclerotherapy. Cardiovasc Intervent Radiol 2018; 41(10): 1505-1512.

Steiner F, FitzJohn T, Tan ST. Ethanol sclerotherapy for venous malformation. ANZ J Surg 2016; 86: 790-5.

Schumacher M, Dupuy P, Bartoli JM, Ernemann U, Herbreteau D, Ghienne C, et al. Treatment of venous malformations: first experience with a new sclerosing agent: a multicenter study. Eur J Radiol 2011; 80(3): e366-72.

Marrocco-Trischitta MM, Nicodemi EM, Stillo F. Sclerotherapy for venous malformations of the glans penis. Urology 2001; 57(2): 310-3.

Marrocco-Trischitta MM, Nicodemi EM, Nater C, Stillo F. Management of congenital venous malformations of the vulva. Obstet Gynecol 2001; 98(5 Pt 1): 789-93.

Gajewska K, Herinckx A, Holoye A, et al. Antenatal embolization of a large chorioangioma by percutaneous Glubran 2 injection. Ultrasound Obstet Gynecol 2010; 36: 773-5.

Desal HA, Toulgoat F, Raoul S, et al. Brain arteriovenous malformations technical note of endovascular treatment with Glubran. Interv Neuroradiol 2005; 11(Suppl. 1): 125-130.

Gandini R, Angelopoulos G, Konda D, et al. Transcatheter Embolization of a Large Symptomatic Pelvic Arteriovenous Malformation with Glubran 2 Acrylic Glue. Cardiovasc Intervent Radiol 2008; 31: 1030-1033.

San Norberto EM, Brizuela JA, Revilla Á, Taylor JH, Vaquero C. Endovascular embolization of a muscular symptomatic arteriovenous malformation with Glubran 2 acrylic glue. Vascular 2015; 23(4): 432-435.

Leonardi M, Barbara C, Simonetti L, Giardino R. Glubran 2: A new acrylic glue for neuroradiological endovascular use. Experimental study on animals. Intervent Neororadiol 2002; 8: 245-50.

Chandra J, Anthony S, Uberoi R. Embolization of the internal iliac artery with Glubran 2 acrylic glue: initial experience with and adjunctive outflow occlusive agent. J Vasc Interv Radiol 2010; 21: 1109-1114.

Raffi L, Simonetti L, Cenni P, et al. Use of Glubran 2 acrylic glue in interventional neuroradiology. Neuroradiology 2007; 49: 829-836.

Uller W, El-sobky S, Alomari AI, Fishman SJ, Spencer SA, Taghinia AH, et al. Preoperative Embolization of Venous Malformations Using n-Butyl Cyanoacrylate. Vascular and Endovascular Surgery 2018; 52(4): 269-274.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.